Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aino I. Telaranta"'
Autor:
Katja Tuononen, Satu Mäki-Nevala, Aino I. Telaranta-Keerie, Sari Hannula, Virinder Kaur Sarhadi, Mikko Juhani Rönty, Kaisa Salmenkivi, Aija Knuuttila, Sonja Lagström, Pekka Ellonen, Aino Wirtanen, Jenny M. Andrews, Sakari Knuutila
Publikováno v:
Genes, Chromosomes and Cancer. 52:503-511
The development of tyrosine kinase inhibitor treatments has made it important to test cancer patients for clinically significant gene mutations that influence the benefit of treatment. Targeted next-generation sequencing (NGS) provides a promising me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a918cf93f24c032bed3624d213483f39
https://doi.org/10.1002/gcc.22047
https://doi.org/10.1002/gcc.22047
Publikováno v:
Proceedings of the National Academy of Sciences. 103:9524-9529
Spermatogonial stem cells (SSCs) are the foundation for spermatogenesis and, thus, preservation of a species. Because of stem cell rarity, studying their self-renewal is greatly facilitated by in vitro culture of enriched biologically active cell pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43fe41529268dd380798dcc6ebe1e0b5
https://doi.org/10.1073/pnas.0603332103
https://doi.org/10.1073/pnas.0603332103
Autor:
Virinder Kaur Sarhadi, Maria P. Gomez, Zoe Dawson, Aino I. Telaranta-Keerie, Satu Mäki-Nevala, Mikko Rönty, Sakari Knuutila, Mike E. Morel, Aija Knuuttila
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 9(6)
Introduction: Among the driver gene mutations in non–small-cell lung cancer, mutations in epidermal growth factor receptor (EGFR) are the most important because of their predictive role in selecting patients eligible for targeted therapy. Our aim w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39162c2542446168c41b9558e84c281a
https://pubmed.ncbi.nlm.nih.gov/24828666
https://pubmed.ncbi.nlm.nih.gov/24828666
Publikováno v:
Immunological reviews. 211
Clones of CD8 + T cells that have been selected in the primary response must have a mechanism by which they can continuously or intermittently generate new effector cells. Several years ago, this mechanism was proposed to involve a self-renewing, ste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d51552568ad1cb8fbabceebedbcc32
https://pubmed.ncbi.nlm.nih.gov/16824121
https://pubmed.ncbi.nlm.nih.gov/16824121
Autor:
Marlene J. Carrasco, Aino I. Telaranta, James M. Carr, Susan M. Kaech, Douglas T. Fearon, Vincenzo Cerundolo, Peter M. Manders, Patricia J. Hunter, Jennifer L. Marshall, Yusuke Murakami, Rafi Ahmed, Michael J. Palmowski
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 102(21)
A characteristic of the secondary response of CD8 + T cells that distinguishes it from the primary response is the generation of greater numbers of effector cells. Because effector CD8 + T cells are derived from a pool of less differentiated, replica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d7e8c47521d7d2398ff67276cac3e2
http://ora.ox.ac.uk/objects/uuid:0b11f9ae-59a2-4214-98fd-bfa4882ad8bc
http://ora.ox.ac.uk/objects/uuid:0b11f9ae-59a2-4214-98fd-bfa4882ad8bc
Autor:
Tuononen, Katja, Mäki‐Nevala, Satu, Sarhadi, Virinder Kaur, Wirtanen, Aino, Rönty, Mikko, Salmenkivi, Kaisa, Andrews, Jenny M., Telaranta‐Keerie, Aino I., Hannula, Sari, Lagström, Sonja, Ellonen, Pekka, Knuuttila, Aija, Knuutila, Sakari
Publikováno v:
Genes, Chromosomes & Cancer; May2013, Vol. 52 Issue 5, p503-511, 9p